Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Consumables, Instruments), Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis), Application (Disease Screening, Pregnancy and Fertility), End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories and Institutes) - Industry Trends and Forecast to 2031.
.
The Global Urinalysis Test Market size was valued at USD 4.16 USD Billion in 2023.
The Global Urinalysis Test Market is projected to grow at a CAGR of 9% during the forecast period of 2024 to 2031.
The major players operating in the market include Abbott (US), Medtronic (US), Siemens (Germany), General Electric Company (US), BD (US), Thermo Fisher Scientific (US), 77 Elektronika Kft (Hungary), Bio-Rad Laboratories Inc. (US), Sysmex Corporation (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Cardinal Health (US), Beckman Coulter Inc. (US), ACON Laboratories Inc. (US), ARKRAY Inc. (Japan), Penn Medicine Lancaster General Health. (US), BioMaxima SA (Poland), Quidel Corporation (US), Metropolis India (India), Dr Lal PathLabs (India), Trinity Biotech (Ireland).
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
